Updates are available Correction dated 2018-06-21

Article History

First Online: 9 May 2018

Change Date: 21 June 2018

Change Type: Correction

Change Details: In the initially published version of this article online in advance of print, a reference (Ajina, A. & Maher, J. Prospects for combined use of oncolytic viruses and CAR T-cells. J. Immunother. Cancer 5, 90 (2017)) was omitted in error from the following sentence: “The ability of oncolytic viruses to increase the expression of MHC class I molecules by cancer cells is also predicted to enhance ACT with TILs or TCR-engineered and chimeric antigen receptor (CAR) T cells that target tumour-specific antigens”. This has been corrected in the HTML and PDF versions of the manuscript.

Competing interests

: H.L.K. is an employee of Replimune, Inc. The remaining authors declare no competing interests.